Jordan Winfield | School of Pharmacy

I received my Bachelor of Science in Cellular and Molecular Biochemistry, Master of Science in Molecular Biology, and Doctor of Pharmacy, all from the University of Texas at El Paso. During my time at the University of Texas at El Paso, I performed research spanning HIV molecular virology and cancer pharmacology. Between 2013-2021, I served in the United States Army and was awarded numerous military awards, including the Army NCO Professional Development Ribbon in 2019. My research focuses on understanding the pharmacokinetic and pharmacodynamic relationships of the metabolic effects of antiretroviral drug exposure. Under the mentorship of Dr. Aaron S. Devanathan, PharmD, PhD, AAHIVP, I will gain skills in pharmacometrics, analytical chemistry, and lipidomics, to discover new insights into the metabolic effects of antiretrovirals and improve patient outcomes in those living with HIV.

Education & Training

PharmD, MS

Fellowship Program Affiliation(s)

Antiretroviral Clinical Pharmacology Fellowship

Practice Area/Expertise

Clinical Pharmacology

Research Interests

Clinical Pharmaceutical Sciences
Biochemical Pharmacology

Research / Project

My research in Dr. Devanathan’s lab focuses on how antiretroviral therapies (ARVs) affect lipid metabolism and increase cardiometabolic risk in people living with HIV (PLWH). Using targeted lipidomics and pharmacokinetic/pharmacodynamic (PK/PD) modeling, the project aims to identify lipid-based biomarkers of ARV-induced metabolic dysfunction. These findings will help uncover the mechanisms driving cardiovascular risk in PLWH and support the development of more accurate, HIV-specific risk prediction tools to guide personalized treatment strategies.

Recent Publications

1. Winfield J, Grigoruta M, Li Y, Meng F, Qin Y, Grimm E, Chen L, Rosenblatt K, Li L (2023). S-nitrosylation of p53 in melanoma alters p53-DNA binding and downstream gene expression. Presented at the American Association for Cancer Research Annual Meeting 2023.

2. Winfield J, Grigoruta M, Qin Y. (2024). Review of Translational Cancer Research Targeting Adenosine Receptor A2AR. Presented at the American Society of Clinical Pharmacology & Therapeutics 2024 Annual Meeting.

3. Winfield J, Mendez IA, Frietze GA. Meta-analysis examining the association between low platelet monoamine oxidase levels and Zuckerman's sensation seeking scale in a sex dependent manner. Front Psychol. 2025 Feb 10;16:1544408. doi: 10.3389/fpsyg.2025.1544408. PMID: 39995434; PMCID: PMC11847826.